Shares of Kineta to commence trading on Nasdaq under new ticker symbol “KA” on December 19, 2022 Seattle, WA — (December 19, 2022) Kineta, Inc. (“Kineta” or the “Company”), a clinical-stage biotechnology company focused on developing next-generation immunotherapies to address [...]
BUSINESS WIRE Recon Capital Advisors, LLC (“RCA”), the investment adviser to the four exchange-traded funds that make up the Recon Capital Series Trust, has entered into an agreement to be acquired by Horizons ETFs Management (USA) LLC (“Horizons USA”), a [...]
PR Newswire NEW YORK, Nov. 1, 2016 NEW YORK, Nov. 1, 2016 /PRNewswire/ -- Crunch, the health club chain best known for making serious fitness fun through unique programming and cutting-edge training, announces the opening of its newest franchise location [...]
Kineta, a Seattle-based biotech startup, has raised an investment round worth almost $1.6 million from existing investors in the company. The investment will be used to fund continued development of the drugs that the company is working on. “This new raise [...]
Seattle biotechnology company Kineta and Seattle Children’s Research Institute are joining in an effort to improve development and testing of therapies for pediatric autoimmune diseases. Their collaboration, called Alliance for Children’s Therapeutics, will be funded both by philanthropic gifts to [...]
Seattle Children’s Research Institute and biotechnology company Kineta, Inc. today launched the Alliance for Children’s Therapeutics (ACT), a first-of-its-kind pediatric research and funding collaboration designed to speed development of new medications for children and teens with lupus nephritis and other autoimmune diseases like multiple sclerosis, [...]
NHL commissioner Gary Bettman slammed the brakes on any Seattle expansion plans Thursday, citing continued uncertainty over construction of a new arena. By Geoff Baker Seattle Times staff reporter NEW YORK — NHL commissioner Gary Bettman slammed the brakes on any [...]
SEATTLE--(BUSINESS WIRE)--Kineta, Inc., a biotechnology company focused on the development of immune-modulating drugs for critical diseases, and RLB Holdings, an investment fund founded by Ray and Lydia Bartoszek, have formed a joint venture, Kineta RLB, LLC, which will commercialize promising, [...]
Dallas, TX -- Nov 18, 2013 / (http://www.myprgenie.com) -- HipLogiq announces today $7 million in series B funding from Hadron Global Partners, a joint venture created to invest in marketing automation, data analytics and eCommerce. Ray Bartoszek, principal of RLB Holdings, and Anthony [...]
Cashing out after Glencore's initial price offering in 2011, ex-Glencore oil traders have formed investment funds and invested in biotechnology. In the past few months, two investment firms founded by ex-Glencore oil traders -- Hydra LLC and RLB Holdings -- [...]
